Microbiome Invest in London on the 23rdof May has an international panel of experts discussing key topics such as the upcoming microbiome trigger points and technologies to watch, the most important recent investment and developments in the microbiome space and how you can commercialise your research and investment advice within microbiome.
The keynote speaker this year will be Isabelle de Cremoux, CEO of Seventure Partners, speaking on Global Microbiome Future Innovation, Partnerships& Trends.
Click here to download the full agenda
With close to 400 microbiome start-ups in 2017 compared to just 12 in 2013, themicrobiome industry has experienced exponential growth, with an increasing number of Biotech and Pharmaceutical companies seeking to capitalise on the translation of research into clinically and commercially viable medicine.Over $616.9 million has been invested in microbiome companies in 2016, more than all venture investment in the microbiome space in 2011 to 2015 combined.
The event will connect over 100 industry executives from early-stage microbiome start-ups,nutrition and pharmaceutical companies, venture capital and private equity investors,regulatory experts and ground-breaking solution providers.
For those looking to attend there is currently a £300 early-bird saving, ending on March 16th.
Further information is available at: microbiomeinvest.com
Microbiome Invest
Date: 23rd May 2018
Location: Novotel London West, 1, Shortlands, W6 8DR
Contact Information: For all inquiries please contact events@kisacoresarch.com or call +44 (0)20 3696 2920.
About Kisaco Research: Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.